Researchers at Weill Cornell Medicine-Qatar (WCM-Q) and Qatar University (QU) have projected that a future herpes simplex virus type 1 (HSV-1) vaccine could substantially reduce oral and genital HSV-1 infections and avert tens of millions of infections over coming decades. The study, titled “Projected Public Health Benefits of a Hypothetical HSV-1 Vaccine in the United States: A Mathematical Modeling Analysis,” was published in the prestigious journal Science Advances and provides the first quantitative assessment of the population-level impact of an HSV-1 vaccine in any population. HSV-1 is one of the ...